Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein (original) (raw)

Abstract

The intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein are cleaved in vitro by human immunodeficiency virus type 1 protease (HIV-1 PR). Microsequencing showed that HIV-1 PR cleaved both human and murine vimentin between leucine-422 and arginine-423 within the sequence between positions 418 and 427, Ser-Ser-Leu-Asn-Leu/Arg-Glu-Thr-Asn-Leu (SSLNL/RETNL). Minor cleavages at other sites were also observed. Heat-denatured vimentin was cleaved by HIV-1 PR less efficiently than native vimentin. A decapeptide containing the sequence SSLN-LRETNL was also cleaved in vitro by HIV-1 PR as predicted. The presence of a charged residue (arginine) at the primary cleavage site distinguishes this from other known naturally occurring cleavage sites. Microinjection of HIV-1 PR into cultured human fibroblasts resulted in a 9-fold increase in the percentage of cells with an altered and abnormal distribution of vimentin intermediate filaments. Most commonly, the intermediate filaments collapsed into a clump with a juxtanuclear localization. These results support the possibility that intermediate filament proteins may serve as substrates within HIV-1-infected cells.

6336

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloemendal H., Pieper F. R. Intermediate filaments: known structure, unknown function. Biochim Biophys Acta. 1989 Apr 12;1007(3):245–253. doi: 10.1016/0167-4781(89)90144-9. [DOI] [PubMed] [Google Scholar]
  2. Chan D., Goate A., Puck T. T. Involvement of vimentin in the reverse transformation reaction. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2747–2751. doi: 10.1073/pnas.86.8.2747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cheng-Mayer C., Rutka J. T., Rosenblum M. L., McHugh T., Stites D. P., Levy J. A. Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci U S A. 1987 May;84(10):3526–3530. doi: 10.1073/pnas.84.10.3526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cheng-Mayer C., Seto D., Tateno M., Levy J. A. Biologic features of HIV-1 that correlate with virulence in the host. Science. 1988 Apr 1;240(4848):80–82. doi: 10.1126/science.2832945. [DOI] [PubMed] [Google Scholar]
  5. Debouck C., Gorniak J. G., Strickler J. E., Meek T. D., Metcalf B. W., Rosenberg M. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc Natl Acad Sci U S A. 1987 Dec;84(24):8903–8906. doi: 10.1073/pnas.84.24.8903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferrari S., Battini R., Kaczmarek L., Rittling S., Calabretta B., de Riel J. K., Philiponis V., Wei J. F., Baserga R. Coding sequence and growth regulation of the human vimentin gene. Mol Cell Biol. 1986 Nov;6(11):3614–3620. doi: 10.1128/mcb.6.11.3614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fischer S., Vandekerckhove J., Ampe C., Traub P., Weber K. Protein-chemical identification of the major cleavage sites of the Ca2+ proteinase on murine vimentin, the mesenchymal intermediate filament protein. Biol Chem Hoppe Seyler. 1986 Nov;367(11):1147–1152. doi: 10.1515/bchm3.1986.367.2.1147. [DOI] [PubMed] [Google Scholar]
  8. Graves M. C., Lim J. J., Heimer E. P., Kramer R. A. An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2449–2453. doi: 10.1073/pnas.85.8.2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Graves M. C., Meidel M. C., Pan Y. C., Manneberg M., Lahm H. W., Grüninger-Leitch F. Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 Dalton subunit of reverse transcriptase. Biochem Biophys Res Commun. 1990 Apr 16;168(1):30–36. doi: 10.1016/0006-291x(90)91670-n. [DOI] [PubMed] [Google Scholar]
  10. Hansen J., Billich S., Schulze T., Sukrow S., Moelling K. Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. EMBO J. 1988 Jun;7(6):1785–1791. doi: 10.1002/j.1460-2075.1988.tb03009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Henderson L. E., Benveniste R. E., Sowder R., Copeland T. D., Schultz A. M., Oroszlan S. Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J Virol. 1988 Aug;62(8):2587–2595. doi: 10.1128/jvi.62.8.2587-2595.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hewick R. M., Hunkapiller M. W., Hood L. E., Dreyer W. J. A gas-liquid solid phase peptide and protein sequenator. J Biol Chem. 1981 Aug 10;256(15):7990–7997. [PubMed] [Google Scholar]
  13. Höner B., Citi S., Kendrick-Jones J., Jockusch B. M. Modulation of cellular morphology and locomotory activity by antibodies against myosin. J Cell Biol. 1988 Dec;107(6 Pt 1):2181–2189. doi: 10.1083/jcb.107.6.2181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kay J., Dunn B. M. Viral proteinases: weakness in strength. Biochim Biophys Acta. 1990 Jan 30;1048(1):1–18. doi: 10.1016/0167-4781(90)90015-t. [DOI] [PubMed] [Google Scholar]
  15. Kohl N. E., Emini E. A., Schleif W. A., Davis L. J., Heimbach J. C., Dixon R. A., Scolnick E. M., Sigal I. S. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686–4690. doi: 10.1073/pnas.85.13.4686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kotler M., Katz R. A., Danho W., Leis J., Skalka A. M. Synthetic peptides as substrates and inhibitors of a retroviral protease. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4185–4189. doi: 10.1073/pnas.85.12.4185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Navia M. A., Fitzgerald P. M., McKeever B. M., Leu C. T., Heimbach J. C., Herber W. K., Sigal I. S., Darke P. L., Springer J. P. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature. 1989 Feb 16;337(6208):615–620. doi: 10.1038/337615a0. [DOI] [PubMed] [Google Scholar]
  18. Nelson W. J., Vorgias C. E., Traub P. A rapid method for the large scale purification of the intermediate filament protein vimentin by single-stranded DNA-cellulose affinity chromatography. Biochem Biophys Res Commun. 1982 Jun 30;106(4):1141–1147. doi: 10.1016/0006-291x(82)91231-1. [DOI] [PubMed] [Google Scholar]
  19. Perides G., Harter C., Traub P. Electrostatic and hydrophobic interactions of the intermediate filament protein vimentin and its amino terminus with lipid bilayers. J Biol Chem. 1987 Oct 5;262(28):13742–13749. [PubMed] [Google Scholar]
  20. Perides G., Kühn S., Scherbarth A., Traub P. Probing of the structural stability of vimentin and desmin-type intermediate filaments with Ca2+-activated proteinase, thrombin and lysine-specific endoproteinase Lys-C. Eur J Cell Biol. 1987 Jun;43(3):450–458. [PubMed] [Google Scholar]
  21. Richards A. D., Roberts R., Dunn B. M., Graves M. C., Kay J. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases. FEBS Lett. 1989 Apr 10;247(1):113–117. doi: 10.1016/0014-5793(89)81251-7. [DOI] [PubMed] [Google Scholar]
  22. Roberts M. M., Oroszlan S. The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. Biochem Biophys Res Commun. 1989 Apr 28;160(2):486–494. doi: 10.1016/0006-291x(89)92459-5. [DOI] [PubMed] [Google Scholar]
  23. Schneider J., Kent S. B. Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease. Cell. 1988 Jul 29;54(3):363–368. doi: 10.1016/0092-8674(88)90199-7. [DOI] [PubMed] [Google Scholar]
  24. Shoeman R. L., Wadle S., Scherbarth A., Traub P. The binding in vitro of the intermediate filament protein vimentin to synthetic oligonucleotides containing telomere sequences. J Biol Chem. 1988 Dec 15;263(35):18744–18749. [PubMed] [Google Scholar]
  25. Singh B., Arlinghaus R. B. Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells. Virology. 1989 Nov;173(1):144–156. doi: 10.1016/0042-6822(89)90230-4. [DOI] [PubMed] [Google Scholar]
  26. Skalka A. M. Retroviral proteases: first glimpses at the anatomy of a processing machine. Cell. 1989 Mar 24;56(6):911–913. doi: 10.1016/0092-8674(89)90621-1. [DOI] [PubMed] [Google Scholar]
  27. Tersmette M., de Goede R. E., Al B. J., Winkel I. N., Gruters R. A., Cuypers H. T., Huisman H. G., Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol. 1988 Jun;62(6):2026–2032. doi: 10.1128/jvi.62.6.2026-2032.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Traub P. Are intermediate filament proteins involved in gene expression? Ann N Y Acad Sci. 1985;455:68–78. doi: 10.1111/j.1749-6632.1985.tb50404.x. [DOI] [PubMed] [Google Scholar]
  29. Vorgias C. E., Traub P. Isolation of glial fibrillary acidic protein from bovine brain white matter and its purification by affinity chromatography on single-stranded DNA-cellulose. Biochem Biophys Res Commun. 1983 Aug 30;115(1):68–75. doi: 10.1016/0006-291x(83)90969-5. [DOI] [PubMed] [Google Scholar]
  30. Vorgias C. E., Traub P. Isolation, purification and characterization of the intermediate filament protein desmin from porcine smooth muscle. Prep Biochem. 1983;13(3):227–243. doi: 10.1080/00327488308064250. [DOI] [PubMed] [Google Scholar]
  31. Weber K., Pringle J. R., Osborn M. Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. Methods Enzymol. 1972;26:3–27. doi: 10.1016/s0076-6879(72)26003-7. [DOI] [PubMed] [Google Scholar]
  32. Willingale-Theune J., Schweiger M., Hirsch-Kauffmann M., Meek A. E., Paulin-Levasseur M., Traub P. Ultrastructure of Fanconi anemia fibroblasts. J Cell Sci. 1989 Aug;93(Pt 4):651–665. doi: 10.1242/jcs.93.4.651. [DOI] [PubMed] [Google Scholar]
  33. Wlodawer A., Miller M., Jaskólski M., Sathyanarayana B. K., Baldwin E., Weber I. T., Selk L. M., Clawson L., Schneider J., Kent S. B. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science. 1989 Aug 11;245(4918):616–621. doi: 10.1126/science.2548279. [DOI] [PubMed] [Google Scholar]
  34. Wood L., Theriault N., Vogeli G. Vimentin cDNA clones covering the complete intermediate-filament protein are found in an EHS tumor cDNA library. Gene. 1989 Mar 15;76(1):171–175. doi: 10.1016/0378-1119(89)90020-6. [DOI] [PubMed] [Google Scholar]
  35. Yoshinaka Y., Luftig R. B. A comparison of avian and murine retrovirus polyprotein cleavage activities. Virology. 1981 May;111(1):239–250. doi: 10.1016/0042-6822(81)90668-1. [DOI] [PubMed] [Google Scholar]